SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Results of Operations for Reportable Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Three Months Ended March 31,
	2026		2025
Infusion services net revenue	$	1,326,007	$	1,311,181
Other revenue (1)	24,647		21,791
Total Option Care Health revenue	1,350,654		1,332,972
(Expense) Income:
Cost of net revenues - drugs	(949,364)		(933,068)
Salaries, benefits, and other employee expense	(216,593)		(205,692)
Other segment items (2)	(97,245)		(99,278)
Depreciation and amortization expense	(14,907)		(15,746)
Interest expense, net	(13,304)		(13,231)
Equity in earnings of joint ventures	1,689		1,729
Other, net	73		(4,130)
Income tax expense	(15,660)		(16,814)
Net Income	$	45,343	$	46,742

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.